Transcript
A (0:01)
Introducing Fidelity Trader plus, the next generation of advanced trading from Fidelity. Customize your tools and charts and access them seamlessly across desktop, web and mobile. For faster trades anywhere you go, try the all new Fidelity Trader Plus. Learn more about our most powerful trading platform yet@fidelity.com TraderPlus investing involves risk, including risk of loss. Fidelity Brokerage Services, LLC member NYSE SIPC introducing Family Freedom from T Mobile. We'll pay off four phones up to 3, 200 and give you four free phones, all on America's largest 5G network. Visit T Mobile.com FamilyFreedom up to 800 per line via virtual prepaid card typically takes 15 days. Free phone via 24 monthly bill credits with finance agreement. Example Apple iPhone 16128 gigs 829.99 Eligible trade in example iPhone 11 Pro for well qualified credits end in balance due if you pay off early or cancel. Contact us.
B (1:00)
You're listening to THE Exchange. Here's today's show.
C (1:06)
Thank you very much, Scott, and happy Friday. Welcome to THE Exchange. I'm Dominic Chewing for Kelly Evans. Today, stocks are lower, capping off a week of losses with the NASDAQ seeing the biggest decline among the major indices. The tech heavy index is down more than 4% this week amid ongoing concerns about the AI trade that's continuing to play out today. Nvidia down about 4% now down 10% for the week. Palantir shares down 14% for the week. Oracle down 11% Broadcom down 7%. You get the idea. One stock, though, that's bucking the trend is Intel. This is on a potential partnership with Tesla. We'll have more on that story coming up ahead. And a check on Bitcoin, trying to finish a volatile week above that key 100,000 level. Currently holding there, but down more than 7% for the week as well. Markets, though, is where we start as big tech earnings delivered but still failed to impress investors this week. And that's not where our next guest is actually looking for some of those opportunities. She is looking at another trade that's been beaten up, but she says the pessimism is now overdone. That would be health care. Joining me now is Julie Beal, chief market strategist over at Kane Anderson Rudnick. Julie, you are now, I think, the third or fourth guest this week that we've talked to that has pointed out health care as a trade. What exactly is attractive to you about it and where would you be going with it?
D (2:27)
I think that the real challenge with the way that the market is set up right now is we have this dependence on everything in AI working out. And I think you also have seen especially in small cap, this swing towards these non earners, non profitable companies. I think balance does the body good and I think nice earnings sustainability does the body good. Within kind of small and mid cap. West Pharmaceutical and Merit Medical, these are both businesses that have the same kind of pharma risk that you have in what you would call small cap pharma. In terms of there's only one product that you're dependent on. They're much more diversified in their businesses. West in particular has a pretty strong level of market share and they're benefiting from GLP1s. But what I think you want overall is just some earnings stability and resilience to add to your portfolio when you have kind of these to the moon bets as well.
